Literature DB >> 30535114

Tofacitinib for familial Mediterranean fever: a new alternative therapy?

Juan Esteban Garcia-Robledo1, Cristian C Aragón1, Ivana Nieto-Aristizabal2, Iván Posso-Osorio2, Carlos A Cañas2, Gabriel J Tobón2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30535114     DOI： 10.1093/rheumatology/key384

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  3 in total

Review 1.  Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review.

Authors:  Hazan Karadeniz; Aslıhan Avanoğlu Güler; Nuh Atas; Hasan Satış; Reyhan Bilici Salman; Hakan Babaoglu; Abdurrahman Tufan
Journal:  Rheumatol Int       Date:  2019-12-07       Impact factor: 2.631

2.  Effectiveness and Safety of JAK Inhibitors in Autoinflammatory Diseases: A Systematic Review.

Authors:  Zhivana Boyadzhieva; Nikolas Ruffer; Gerd Burmester; Anne Pankow; Martin Krusche
Journal:  Front Med (Lausanne)       Date:  2022-06-27

Review 3.  Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence-Based Approach and Proposal of a Practical Guide.

Authors:  Alessandra Soriano; Marco Soriano; Gerard Espinosa; Raffaele Manna; Giacomo Emmi; Luca Cantarini; José Hernández-Rodríguez
Journal:  Front Immunol       Date:  2020-06-03       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.